[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UA85801U - Method for evaluation of effectiveness of treatment of patients with chronic obstructive lund disease combined with metabolic syndrome - Google Patents

Method for evaluation of effectiveness of treatment of patients with chronic obstructive lund disease combined with metabolic syndrome

Info

Publication number
UA85801U
UA85801U UAU201308750U UAU201308750U UA85801U UA 85801 U UA85801 U UA 85801U UA U201308750 U UAU201308750 U UA U201308750U UA U201308750 U UAU201308750 U UA U201308750U UA 85801 U UA85801 U UA 85801U
Authority
UA
Ukraine
Prior art keywords
treatment
effectiveness
patients
evaluation
chronic obstructive
Prior art date
Application number
UAU201308750U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Светлана Анатолиевна Бычкова
Татьяна Ильинична Гавриленко
Нина Григорьевна Бычкова
Александр Анатольевич Красюк
Original Assignee
Национальный Медицинский Университет Им. А. А. Богомольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Медицинский Университет Им. А. А. Богомольца filed Critical Национальный Медицинский Университет Им. А. А. Богомольца
Priority to UAU201308750U priority Critical patent/UA85801U/en
Publication of UA85801U publication Critical patent/UA85801U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The method for evaluation of effectiveness of treatment of patients with chronic obstructive lung disease in combination with metabolic syndrome includes blood examination. In blood serum before and after treatment the concentration of circulating immune complexes with large, medium and small dimensions is determined using spectrophotometer. At decrease of concentration of CIC with medium and small dimensions and increase of concentration of the CIC with large dimensions the treatment is evaluated as effective.
UAU201308750U 2013-07-12 2013-07-12 Method for evaluation of effectiveness of treatment of patients with chronic obstructive lund disease combined with metabolic syndrome UA85801U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201308750U UA85801U (en) 2013-07-12 2013-07-12 Method for evaluation of effectiveness of treatment of patients with chronic obstructive lund disease combined with metabolic syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201308750U UA85801U (en) 2013-07-12 2013-07-12 Method for evaluation of effectiveness of treatment of patients with chronic obstructive lund disease combined with metabolic syndrome

Publications (1)

Publication Number Publication Date
UA85801U true UA85801U (en) 2013-11-25

Family

ID=52285318

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201308750U UA85801U (en) 2013-07-12 2013-07-12 Method for evaluation of effectiveness of treatment of patients with chronic obstructive lund disease combined with metabolic syndrome

Country Status (1)

Country Link
UA (1) UA85801U (en)

Similar Documents

Publication Publication Date Title
EA201400119A1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND THEIR APPLICATION
TN2015000283A1 (en) FUNCTIONALIZED EXENDIN-4 DERIVATIVES
CA2909335C (en) Fenfluramine for use in the treatment of dravet syndrome
EA201491584A1 (en) METHODS OF TREATING NON-SMALL-CELL LUNG CANCER WITH THE USE OF COMBINED TREATMENT WITH KINASE TOR INHIBITOR
EA033286B1 (en) Method of treating or delaying the progression of chronic kidney disease
EA201690617A1 (en) COMBINING ANTI-LAG-3-ANTIBODIES AND ANTI-PD-1-ANTIBODIES FOR THE TREATMENT OF TUMORS
WO2014005010A3 (en) Methods of treating breast cancer with gemcitabine therapy
EA201500997A1 (en) THERAPEUTIC APPLICATIONS OF EMAGOGLIFLOSINE
MY174894A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
PH12015502275A1 (en) Therapuetic uses of empagliflozin
MX336145B (en) Method of treating chronic heart failure.
WO2012125828A8 (en) Methods of treating breast cancer with anthracycline therapy
WO2013082440A3 (en) Methods of treating breast cancer with taxane therapy
EA201691314A1 (en) THERAPEUTIC WAYS AND COMPOSITIONS
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
WO2014205266A3 (en) Compositions and methods for detecting and treating glioblastoma
MX2015015036A (en) Methods for improving lipid profiles using atrasentan.
FR2979346B1 (en) NANOCORPS ANTI-VCAM-1
MX2016006584A (en) Methods and compositions for treating amyloid deposits.
BR112015027249A2 (en) cancer diagnosis method
WO2014169011A3 (en) Methods for treating immune diseases
EA201491455A1 (en) EFFECTORS β-ARRESTINA, COMPOSITIONS, THEIR CONTAINING, AND METHODS OF THEIR USE
UA85801U (en) Method for evaluation of effectiveness of treatment of patients with chronic obstructive lund disease combined with metabolic syndrome
WO2015092444A3 (en) Biomarkers
RU2013155841A (en) METHOD FOR EARLY DIAGNOSIS OF CHRONIC KIDNEY DISEASE